IFPMA tightens Code of Practice for health interactions

The International Federation of Pharmaceutical Manufacturers and Associations’ (IFPMA) Code of Practice as this might be of interest to The Pharma Letter. The Code has been updated the industry’s Code of Practice to cover ethical and professional standards for promotional activities to include all interactions with health care professionals, medical institutions and patient organizations.

Representing the research-based pharmaceutical industry, the IFPMA requires all member companies and member associations around the world to adopt and implement this new Code.

“Advancing medical knowledge and improving global public health depend on regular information sharing interactions between the medical community and pharmaceutical companies. These exchanges ensure patients benefit from the most up-to-date information regarding medicines,” says Eduardo Pisani, IFPMA director general, adding: “Ensuring that governments, health care providers and patients are confident that interactions with our members are conducted to the highest ethical and professional standards is our commitment.”